$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Viral Respiratory Tract Infection Global Clinical Trials Review, H2, 2015
[Published by Global Data]

Published by Global Data: 25 Nov 2015 | 17572 | In Stock
Related Topics: Clinical Trials , Respiratory

Introduction

Viral Respiratory Tract Infection Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Viral Respiratory Tract Infection Global Clinical Trials Review, H2, 2015" provides an overview of Viral Respiratory Tract Infection clinical trials scenario. This report provides top line data relating to the clinical trials on Viral Respiratory Tract Infection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Viral Respiratory Tract Infection Global Clinical Trials Review, H2, 2015 [Published by Global Data]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 3

    Report Guidance 4

    Clinical Trials by Region 5

    Clinical Trials and Average Enrollment by Country 6

    Top Countries Contributing to Clinical Trials in Asia-Pacific 8

    Top Countries Contributing to Clinical Trials in Europe 9

    Top Countries Contributing to Clinical Trials in North America 10

    Top Countries Contributing to Clinical Trials in Middle East and Africa 11

    Top Countries Contributing to Clinical Trials in Central and South America 12

    Clinical Trials by G7 Countries: Proportion of Viral Respiratory Tract Infection to Respiratory Clinical Trials 13

    Clinical Trials by Phase in G7 Countries 14

    Clinical Trials by E7 Countries: Proportion of Viral Respiratory Tract Infection to Respiratory Clinical Trials 15

    Clinical Trials by Phase in E7 Countries 16

    Clinical Trials in E7 Countries by Trial Status 17

    Clinical Trials by Phase 18

    In Progress Trials by Phase 19

    Clinical Trials by Trial Status 20

    Clinical Trials by End Point Status 21

    Subjects Recruited Over a Period of Time 22

    Clinical Trials by Sponsor Type 23

    Prominent Sponsors 24

    Top Companies Participating in Viral Respiratory Tract Infection Therapeutics Clinical Trials 25

    Prominent Drugs 26

    Clinical Trial Profile Snapshots 27

    Appendix 37

    Abbreviations 37

    Definitions 37

    Research Methodology 38

    Secondary Research 38

    About GlobalData 39

    Contact Us 39

    Disclaimer 39

    Source 40

List Of Tables
in Viral Respiratory Tract Infection Global Clinical Trials Review, H2, 2015 [Published by Global Data]

List of Tables

Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials by Region, 2015* 5

Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6

Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 7

Viral Respiratory Tract Infection Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 8

Viral Respiratory Tract Infection Therapeutics Clinical Trials, Europe, Top Countries, 2015* 9

Viral Respiratory Tract Infection Therapeutics Clinical Trials, North America, Top Countries, 2015* 10

Viral Respiratory Tract Infection Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 11

Viral Respiratory Tract Infection Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 12

Proportion of Viral Respiratory Tract Infection to Respiratory Clinical Trials, G7 Countries (%), 2015* 13

Viral Respiratory Tract Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Proportion of Viral Respiratory Tract Infection to Respiratory Clinical Trials, E7 Countries (%), 2015* 15

Viral Respiratory Tract Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 16

Viral Respiratory Tract Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 17

Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials by Phase, 2015* 18

Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19

Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20

Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21

Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22

Viral Respiratory Tract Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23

Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24

Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25

Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26

List Of Figures, Charts and Diagrams
in Viral Respiratory Tract Infection Global Clinical Trials Review, H2, 2015 [Published by Global Data]

List of Figures

Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials by Region (%), 2015* 5

Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6

Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 7

Viral Respiratory Tract Infection Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 8

Viral Respiratory Tract Infection Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 10

Proportion of Viral Respiratory Tract Infection to Respiratory Clinical Trials, G7 Countries (%), 2015* 13

Viral Respiratory Tract Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Proportion of Viral Respiratory Tract Infection to Respiratory Clinical Trials, E7 Countries (%), 2015* 15

Viral Respiratory Tract Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 16

Viral Respiratory Tract Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 17

Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18

Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19

Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20

Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21

Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22

Viral Respiratory Tract Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23

Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24

Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25

Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26

GlobalData Methodology 38

Additional Details

Publisher

Global Data

Publisher Information

Reference

17572 | GDHC2979CTIDB

Number of Pages

40

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Viral Partnering 2010-2016: Deal trends, players and financials
Global Viral Partnering 2010 to 2016 provides the full collection of Viral disease deals signed betw...
01 Nov 2016 by Current Partnering USD $2,995 More Info
Global Viral Partnering 2010-2016: Deal trends, players and financials
Global Viral Partnering 2010 to 2016 provides the full collection of Viral disease deals signed betw...
01 Oct 2016 by Current Partnering USD $2,995 More Info
Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) - Global Forecast to 2021
The global viral inactivation market is projected to reach USD 573.0 million by 2021 from USD 320.5 ...
06 Jun 2016 by MarketsandMarkets USD $5,650 More Info
Vybion, Inc (formerly Viral Therapeutics, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
SummaryMarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments r...
15 Apr 2016 by Marketline USD $350 More Info
Global Viral Infections Market to 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics
Global Viral Infections Market to 2021 - Promising New Competitors and Expanding Treatment Populatio...
05 Apr 2016 by GBI Research USD $4,995 More Info
Global Viral Infections Market to 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics
Global Viral Infections Market to 2021 - Promising New Competitors and Expanding Treatment Populatio...
05 Apr 2016 by GBI Research USD $4,995 More Info
Viral Clearance Market by Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Inactivation, Removal (Precipitation), Detection (PCR, ELISA)) & End User (Pharmaceutical & Biotechnology, CROs, Research Institute) - Global Forecast to 2020
The global viral clearance market is projected to reach USD 510.3 million by 2020 from USD 285.5 mil...
04 Apr 2016 by MarketsandMarkets USD $4,650 More Info
Epstein-Barr Viral Infections Global Clinical Trials Review, H2, 2015
Epstein-Barr Viral Infections Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical tr...
30 Dec 2015 by Global Data USD $2,500 More Info
Viral Bronchiolitis Global Clinical Trials Review, H2, 2015
Viral Bronchiolitis Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report...
25 Nov 2015 by Global Data USD $2,500 More Info
Transfection Reagents and Equipment Market by Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral) & by Application (Biomedical, Protein Production) - Analysis & Global Forecast to 2020
Over the years, the transfection reagents and equipment market has witnessed various technological a...
01 Jul 2015 by MarketsandMarkets USD $5,650 More Info

This report is published by Global Data

Download Free Report Summary PDF

Viral Respiratory Tract Infection Global Clinical Trials Review, H2, 2015 [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...